acyclovir NDC 16714-885

NDC codes

FDA NDC Directory

Product NDC (as listed)16714-885Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16714-0885Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
16714-885-01	16714088501	1 TUBE in 1 CARTON (16714-885-01) / 15 g in 1 TUBEMarketed from Dec 31, 2018
16714-885-02	16714088502	1 TUBE in 1 CARTON (16714-885-02) / 30 g in 1 TUBEMarketed from Dec 31, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): acyclovir
Generic name (nonproprietary): acyclovir
Active ingredients: Acyclovir — 50 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Northstar Rx LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205510
Marketing start: Jul 31, 2017
Listing expires: Dec 31, 2027
Other FDA classes: DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
Identifiers: Product ID 16714-885_b8c9f3ec-f227-421a-be72-29e8d533ab1dSPL ID b8c9f3ec-f227-421a-be72-29e8d533ab1dSPL set ID 6788f3c6-b79c-4f3f-9a73-10c8d3a38267RxCUI 197312UNII X4HES1O11FUPC 0316714885018
Pharmacologic class: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416714088501 followed by a unit qualifier and the quantity

Package 16714-0885-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 17, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Acyclovir ointment USP 5% is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous Herpes simplex virus infections in immunocompromised patients.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 205510

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205510
Product	Strength	Form · route	Labeler	Product NDC
acyclovir	Acyclovir 50 mg/g	OintmentTopical	NuCare Pharmaceuticals, Inc.	68071-3909
acyclovir	Acyclovir 50 mg/g	OintmentTopical	Glenmark Pharmaceuticals Inc., USA	68462-746
acyclovir	Acyclovir 50 mg/g	OintmentTopical	A-S Medication Solutions	50090-6561